At the American Society of Retina Specialists meeting, new data showed a significant proportion of patients treated for geographic atrophy (GA) also had neovascular age-related macular degeneration ...

As of March 2026, the number of approved biosimilars in the United States had reached 92 across 20 unique biological molecules, of which 73% had been launched in the market.

Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Conjugation of universal, functionally de-targeted OneAAVTM capsid provides on-demand specificity and scalabilityto address ...

Regeneron eyes Q1 results with Dupixent profits and strong Eylea HD uptake set to offset declining Eylea sales amid rising ...

A key imaging finding in the fellow eye of patients with unilateral neovascular age-related macular degeneration (nAMD) ...

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 12, 2026. NASHVILLE, Tenn., April 27, ...

Most people are aware that smoking cigarettes is bad for our health. However, the negative effects are far more extensive ...

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...